A Case of Gastric Juvenile-Type Polyposis With SMAD4 Mutation Authors: Meung Chul Park, So Hyun Jeon, Chang Hun Park, Hee Kyung Kim, Su Jin Hong Published: 2026 ABSTRACT AbstractJuvenile polyposis syndrome (JPS) is a rare autosomal-dominant disorder characterized by the presence of multiple hamartomatous polyps in the gastrointestinal tract. JPS has been established to be attributable to SMAD4 mutations, which are frequently associated with severe gastric phenotypes and hereditary hemorrhagic telangiectasia. We report the case of a 39-year-old woman with a history of immature teratoma, who presented with persistent anemia and upper gastrointestinal bleeding. Endoscopy revealed multiple gastric polyps, including a 5-cm polyp at the cardia. She underwent repeated endoscopic mucosal resections, with the initial histopathologic findings being consistent with hyperplastic polyps. Next-generation sequencing identified a pathogenic SMAD4 mutation, confirming the diagnosis of gastric juvenile-type polyposis. This case highlights the importance of considering hereditary polyposis syndromes in patients with multiple gastric polyps and anemia, even in the absence of a family history. Early genetic testing facilitates accurate diagnosis and enables appropriate endoscopic surveillance and management, as well as screening for extra-gastrointestinal manifestations.Keywords: Juvenile polyposis syndrome, SMAD4 protein, Stomach, Polyps, Genetic testing INTRODUCTION Juvenile polyposis syndrome (JPS) is a rare autosomal dominant hereditary disorder characterized by the development of multiple hamartomatous polyps in the gastrointestinal tract [1]. Although polyps can arise throughout the gastrointestinal tract, isolated massive gastric involvement is uncommon and has been associated with an increased risk of gastric carcinoma. Mutations in SMAD4 and BMPR1A are known genetic causes of JPS, with SMAD4 mutations frequently associated with more severe gastric phenotypes and concurrent features of hereditary hemorrhagic telangiectasia (HHT) [2,3]. In particular, gastric juvenile-type polyposis with SMAD4 mutation represents a rare but clinically challenging manifestation, often characterized by extensive gastric polyposis that may require surgical intervention [4]. Gastrointestinal bleeding and anemia can occur in this condition but are often underrecognized, especially in patients without family history. Due to its rarity, clinicopathological characteristics and optimal management strategies remain poorly defined. We report a case of extensive gastric juvenile polyposis associated with a SMAD4 germline mutation and discuss the clinical, endoscopic, histologic, and genetic features in the context of current literature. CASE REPORT A 39-year-old female patient with no family history of gastrointestinal polyposis presented with persistent anemia and endoscopic evaluation revealed ongoing gastrointestinal bleeding with an oozing appearance from a large gastric polyp. Her medical history included a grade 3 immature teratoma diagnosed 16 years before presentation, at the age of 23 years, for which she underwent left oophorectomy and achieved complete remission. Fourteen years before presentation, at the age of 25 years, she underwent endoscopic retrograde cholangiopancreatography for a distal common bile duct stone. A baseline esophagogastroduodenoscopy (EGD) performed 16 years before presentation (at age 23) demonstrated chronic gastritis with no evidence of gastric polyps. However, an upper gastrointestinal endoscopy performed five months prior to the current visit revealed a 5-cm polyp located at the gastric cardia, along with multiple additional polyps scattered throughout the stomach. On admission, her vital signs were as follows: blood pressure 105/70 mm Hg, pulse rate 86/min, respiratory rate 16/min, and body temperature 37.3°C. Physical examination and chest radiography were unremarkable. During hospitalization, gastric endoscopic mucosal resection (EMR) was performed and the 5-cm polyp at the cardia was successfully removed. Additional polyps of similar size were also observed on the lesser curvature at the gastric angle. Scattered polypoid lesions were noted in the gastric body, while the antrum exhibited linear erythema and granular surface elevation due to inflammation (Fig. 1). A total of 5 additional polyps were resected. The resected polyps were interpreted as hyperplastic polyps based on histologic findings alone. Endoscopic findings during the first session of gastric EMR. A: Multiple gastric polyps, including a large polyp at the cardia. B: Polyps in the lower gastric body. C: A polyp at the gastric angle. D: Magnified view of the gastric angle polyp. E: Intra-procedural image of EMR at the cardia. F: Resected polyps following EMR. EMR, endoscopic mucosal resection. A secondary gastric EMR was performed 10 months after the initial procedure. At that time, the overall number of gastric polyps had decreased; however, a recurrent 4-cm polyp was identified at the site of the previously resected largest polyp. Histologic evaluation again suggested a hyperplastic polyp based on morphologic features alone. To investigate the underlying etiology, further testing was conducted, including measurement of pepsinogen I & II ratio, anti-parietal cell antibody, anti-intrinsic factor antibody, and next-generation sequencing (NGS) for hereditary cancer syndromes. The pepsinogen I/II ratio was within the normal range, and the antibody tests were negative. Germline genetic testing using NGS revealed a pathogenic SMAD4 mutation, confirming the diagnosis of gastric juvenile-type polyposis associated with SMAD4 (Fig. 2). Next-generation sequencing analysis showing a pathogenic SMAD4 variant (c.538C>T; p.Gln180*). On the colonoscopy performed at that time, only inflammatory polyps were identified, and no other characteristic hamartomatous polyps were observed. At the 18-month follow-up EGD, recurrent gastric polyps were observed. During the same examination, hamartomatous polyps were also noted, with a tendency to extend toward the antrum (Fig. 3). Follow-up esophagogastroduodenoscopy at 18 months showing multiple recurrent gastric polyps. A: Recurrent gastric polyps at the cardia. B: Newly observed polyps in the antrum. C: After polyp resection at the cardia. D: After polyp resection at antrum. The most recent surveillance EGD was performed two years after the initial examination (Fig. 4). During this procedure, multiple regrown gastric polyps were again identified, and endoscopic polypectomy was performed. Finally, based on appropriate clinical and endoscopic findings, the lesions were diagnosed as hamartomatous polyps. Microscopic evaluation of the polyps obtained during the most recent endoscopic polypectomy demonstrated characteristic features of juvenile polyps, including irregular hyperplastic and cystically dilated glands lined by foveolar epithelium embedded within an abundant edematous stroma (Fig. 5). Follow-up esophagogastroduodenoscopy at 2 years showing multiple regrown gastric polyps. Histopathologic findings of a juvenile polyp. A: Irregular hyperplastic and cystically dilated glands within an edematous stroma (H&E, ×20). B: Glands lined by foveolar epithelium with abundant edematous stroma (H&E, ×40). H&E, hematoxylin and eosin. The patient refused prophylactic total gastrectomy and has therefore decided to undergo careful endoscopic surveillance. Surgical intervention, including total gastrectomy, will be considered if dysplasia develops or if the patient shows significant clinical progression. DISCUSSION JPS predominantly involves the lower gastrointestinal tract. However, JPS associated with SMAD4 mutations is known to be characterized by more aggressive gastric polyposis and a higher risk of gastric cancer [2]. The diagnosis of JPS is established in a proband when any one of the following criteria is met: 1) more than five juvenile polyps of the colon or rectum, 2) multiple juvenile polyps of the upper and lower gastrointestinal tract, 3) any number of juvenile polyps and a family history of juvenile polyposis, and 4) identification of a heterozygous pathogenic variant in genes associated with JPS, including SMAD4, BMPR1A, PTEN and possibly ENG [1,5]. Approximately 50% of patients with JPS have no family history of polyposis, suggesting the presence of a de novo pathogenic variant [1]. In the present case, no family history of polyposis was identified, and no gastric polyps were observed on EGD performed 16 years before presentation (at age 23). Therefore, this case is considered to have arisen de novo. Although the majority of juvenile polyps are benign, the lifetime risk of gastrointestinal cancer in patients with JPS has been reported to range from 11% to 86%. Notably, in patients with gastric polyps, the risk of gastric cancer increases to as high as 21%. Accordingly, prophylactic total gastrectomy has been considered in selected patients with SMAD4 mutation-associated gastric juvenile polyposis [4,6,7]. In a study by Gonzalez et al. [6], cancer or dysplasia was identified in 11 of 22 surgically treated cases (50%). Given these findings, close surveillance with regular endoscopic follow-up is essential to monitor for the development of dysplasia or malignancy. In the present case, gastric polyposis was the predominant manifestation, consistent with the prominent gastric involvement reported in SMAD4-associated JPS. Although extensive gastric polyposis may ultimately require surgical management, repeated endoscopic resection allowed temporary control of the polyp burden in our patient. These findings highlight the potential role of endoscopic surveillance and resection in selected patients before considering more aggressive surgical approaches. Patients with SMAD4 mutation should also be evaluated for the possible coexistence of HHT. The diagnosis of HHT is based on the Curaçao criteria, which include: 1) spontaneous and recurrent epistaxis; 2) multiple mucocutaneous telangiectases at characteristic sites, including the lips, oropharynx, fingers, and nose; 3) visceral involvement, such as gastrointestinal telangiectasia or pulmonary, hepatic, cerebral, or spinal arteriovenous malformation; and 4) a first-degree family history of HHT [8]. A diagnosis of HHT requires the presence of at least three of these four criteria. Although none of these features were present in our patient, concurrent evaluation is warranted when gastric polyposis and SMAD4 mutations are identified. Endoscopically, the gastric polyposis in this case demonstrated features suggestive of hamartomatous polyps. However, histologic diagnosis of gastric juvenile polyps can be challenging, as their unusual morphology may closely resemble that of hyperplastic polyps [9]. This histologic overlap is well recognized, and distinction between these entities may be challenging based on histologic findings alone. JPS with predominant gastric involvement in the absence of colonic polyposis is uncommon and may further complicate the diagnostic process. The diagnosis of gastric juvenile polyposis is therefore typically established in the appropriate clinical context. In such cases, genetic testing using NGS, in addition to histopathologic evaluation, may help establish the correct diagnosis and differentiate JPS from other gastric polyposis syndromes such as Cowden syndrome or Ménétrier disease. Finally, this patient developed ovarian cancer at the age of 24 and a common bile duct stone at the age of 26. Although no established association between these conditions and SMAD4 mutations has been reported, further studies are required to determine whether these findings may have any potential relationship with SMAD4-related disease. Footnotes Availability of Data and Material The datasets generated or analyzed during the study are available from the corresponding author on reasonable request. Conflicts of Interest The authors have no financial conflicts of interest. Funding Statement None Acknowledgements None Authors’ Contribution Conceptualization: Su Jin Hong. Data curation: So Hyun Jeon, Meung Chul Park, Chang Hun Park, Hee Kyung Kim. Formal analysis: Meung Chul Park. Investigation: Meung Chul Park, So Hyun Jeon. Methodology: Meung Chul Park. Project administration: Meung Chul Park, Su Jin Hong. Resources: So Hyun Jeon, Chang Hun Park, Hee Kyung Kim. Supervision: Su Jin Hong. Validation: So Hyun Jeon. Visualization: So Hyun Jeon. Writing—original draft: Meung Chul Park, So Hyun Jeon. Writing—review & editing: Meung Chul Park, So Hyun Jeon, Su Jin Hong. Approval of final manuscript: all authors. Ethics Statement This study was exempted from review by the Institutional Review Board of Soonchunhyang University Bucheon Hospital due to the retrospective nature of this case report (IRB No. 2026-04-026), and the requirement for informed consent was waived. REFERENCES